Current filters:

Clear current filters  or Add more filters

View Option

Results 1-10 of 14 (Search time: 0.018 seconds).

  High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria (Journal article)

  Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemia (Journal article)

  PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin (Journal article)

  Platelet derived microparticles inhibit Cu2+-induced LDL oxidation (Journal article)

  Long-term treatment with EPO increases serum levels of high-density lipoprotein in patients with CKD (Journal article)

  Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A(2) (Journal article)

  Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: Effect of long-term therapy with erythropoietin (Journal article)

  Erythropoietin administration in patients with chronic renal failure prevents the decrease in RBC-associated antioxidant enzyme activities (Journal article)

  Epoetin alpha increases plasma HDL levels and HDL-associated PAF-acetylhydrolase activity in patients with chronic renal failure (Journal article)

  Production and secretion of the lipoprotein-associated phospholipase A2 (LpPLA2) from blood monocytes of patients with early rheumatoid arthritis: Effect of disease modifying antirheumatic drugs administration (Journal article)